A new part of an ocean plant cell has been discovered that might revolutionize farming one day. The structure can take ...

Our critic on the month’s best releases. By Alida Becker A new book collects the Paper Magazine co-founder Kim Hastreiter’s most treasured belongings, and friends. By Tas Tobey In “The M ...

Suggested reading from critics and editors at The New York Times. We bring you a true grab bag of recommended books this week, united by little besides excellence and interest. There’s a ...

Investors' deep pessimism is actually bullish, and less regulatory constraint could fuel new drug approval and M&A Biotech is one of the U.S. stock market's most unloved sectors. But several ...

Why Infinium, Zum, and Copper are among Fast Company's Most Innovative Companies in the sustainability space for 2025.

Join biotech commentators Daphne Zohar, Josh Schimmer, and Brad Loncar for a weekly discussion of all things biotech. From emerging trends and investment opportunities to the challenges facing the ...

Biotech stocks are oversold. This near-term bottom might be the start of a long-term bull run. IBB and XBI offer different advantages. IBB can benefit from the flight to safety trade. XBI provides ...

CBSE 2025 Class 12 Biotechnology Syllabus : The Central Board of Secondary Education (CBSE) Senior Secondary Class 12 Biotechnology syllabus has been released. Students can directly access the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

And like many other young players in the biotechnology business, this one's also still booking sizable losses, adding to investors' general disinterest. What this company lacks in size and profits ...